These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3535253)

  • 41. p53 (TRP53) deficiency-mediated antiapoptosis escape after 5 Gy X irradiation still induces stem cell leukemia in C3H/He mice: comparison between whole-body assay and bone marrow transplantation (BMT) assay.
    Yoshida K; Hirabayashi Y; Wada S; Watanabe F; Watanabe K; Aizawa S; Inoue T
    Radiat Res; 2007 Jun; 167(6):703-10. PubMed ID: 17523849
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The human tumor cloning assay in cancer research and therapy: a review with clinical correlations.
    Hanauske AR; Hanauske U; Von Hoff DD
    Curr Probl Cancer; 1985 Dec; 9(12):1-66. PubMed ID: 2419036
    [No Abstract]   [Full Text] [Related]  

  • 43. [On resistance to antineoplastic drugs].
    Hoshino A
    Nihon Rinsho; 1969 Jun; 27(6):1566-70. PubMed ID: 5816825
    [No Abstract]   [Full Text] [Related]  

  • 44. Current therapy of acute leukoses and myelosuppressive effect of cytostatics in the course of treatment.
    Hauptmann E
    Lijec Vjesn; 1978 Jun; 100(6):376. PubMed ID: 703494
    [No Abstract]   [Full Text] [Related]  

  • 45. Severe combined immunodeficient mouse models of human leukemia.
    Uckun FM
    Blood; 1996 Aug; 88(4):1135-46. PubMed ID: 8695830
    [No Abstract]   [Full Text] [Related]  

  • 46. Some biologic regulating factors of proliferation and differentiation in acute leukemias.
    Berceanu S; Papazian R
    Rev Roum Med Intern; 1974; 11(2):163-71. PubMed ID: 4824730
    [No Abstract]   [Full Text] [Related]  

  • 47. Lack of correlation between antitumour response and serum interferon levels in mice treated with SSM, an immunotherapeutic anticancer agent.
    Suzuki F; Brutkiewicz RR; Pollard RB
    Br J Cancer; 1986 Apr; 53(4):567-70. PubMed ID: 3085702
    [No Abstract]   [Full Text] [Related]  

  • 48. [Reserve potentials of cytostatic therapy in experimental acute leukemia].
    Svirnovskiĭ AI
    Gematol Transfuziol; 1987 Jun; 32(6):34-8. PubMed ID: 3623056
    [No Abstract]   [Full Text] [Related]  

  • 49. How does leukemia invade the central nervous system?
    Pochedly C
    Postgrad Med; 1976 Jan; 59(1):101-5. PubMed ID: 1246530
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chloroma regression induced by the granulocytic chalone.
    Rytömaa T; Kiviniemi K
    Nature; 1969 Jun; 222(5197):995-6. PubMed ID: 5789335
    [No Abstract]   [Full Text] [Related]  

  • 51. [Pharmacological induction of leukemia cell differentiation].
    Aarbakke J
    Tidsskr Nor Laegeforen; 1988 Feb; 108(6):488-90. PubMed ID: 3353950
    [No Abstract]   [Full Text] [Related]  

  • 52. [Progress in hematology. Therapy of acute leukemias].
    Kopeć M; Plachecka-Gutowska M
    Pol Arch Med Wewn; 1966; 36(6):883-7. PubMed ID: 5330093
    [No Abstract]   [Full Text] [Related]  

  • 53. Interleukin 2 in the management of hematologic malignancies.
    Foà R; Meloni G; Guarini A; Vignetti M; Mandelli F; Gavosto F
    Pharmacol Res; 1992 Sep; 26 Suppl 2():82-3. PubMed ID: 1409333
    [No Abstract]   [Full Text] [Related]  

  • 54. [Stem cell kinetics of bone marrow in relation to cytostatic treatment].
    Laerum OD
    Tidsskr Nor Laegeforen; 1971 Jun; 91(16):1207-9 passim. PubMed ID: 4935674
    [No Abstract]   [Full Text] [Related]  

  • 55. [Experimental study on preparations and methods used in the treatment of leukemia].
    Zaretskiĭ II
    Probl Gematol Pereliv Krovi; 1965 Nov; 10(11):9-14. PubMed ID: 5334274
    [No Abstract]   [Full Text] [Related]  

  • 56. Kinetics of normal and leukemic leukocyte populations and relevance to chemotherapy.
    Skipper HE; Perry S
    Cancer Res; 1970 Jun; 30(6):1883-97. PubMed ID: 4917694
    [No Abstract]   [Full Text] [Related]  

  • 57. [Methods of determining blast cell sensitivity to chemical preparations in treating leukemias (a review of the literature)].
    Evtukh VP
    Vrach Delo; 1986 Aug; (8):42-6. PubMed ID: 3535253
    [No Abstract]   [Full Text] [Related]  

  • 58. Development of erythroleukemia in Rauscher virus infected mice treated with phytohemagglutinin.
    Lozzio BB; Brown A; Hewins JP
    Exp Hematol; 1974; 2(1):16-27. PubMed ID: 4532081
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.